0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Hepatitis A - Epidemiology Forecast to 2028
Published Date: April 2019
|
Report Code: DELV-Epid-224
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Hepatitis A  Epidemiology Forecast to 2028

Hepatitis A - Epidemiology Forecast to 2028

Code: DELV-Epid-224
Report
April 2019
50 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

DelveInsight's "Hepatitis A - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Hepatitis A epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2028

Hepatitis A Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Hepatitis A in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Hepatitis A outlook. It also includes the explanation of changing trends of epidemiology outlining the Hepatitis A scenario.

Hepatitis A Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Hepatitis A thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Hepatitis A explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Hepatitis A Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Hepatitis A

Key assessments
• Patient Segmentation in Hepatitis A
• Hepatitis A Risk & Burden
• Factors driving growth in a specific Hepatitis A patient population

1. Report Introduction
2. Hepatitis A Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Hepatitis A in 2016
2.2. Patient Share Distribution of Hepatitis A in 2028
3. Disease Background and Overview: Hepatitis A
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Hepatitis A in 7MM
4.3. Total Prevalent/ Incident Patient Population of Hepatitis A in 7MM – By Countries
5. Epidemiology of Hepatitis A by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Hepatitis A
5.1.3. Sub-Type Specific cases of the Hepatitis A *
5.1.4. Sex- Specific Cases of the Hepatitis A *
5.1.5. Diagnosed Cases of the Hepatitis A
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Hepatitis A
5.4.3. Sub-Type Specific cases of the Hepatitis A *
5.4.4. Sex- Specific Cases of the Hepatitis A *
5.4.5. Diagnosed Cases of the Hepatitis A
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Hepatitis A
5.5.3. Sub-Type Specific cases of the Hepatitis A *
5.5.4. Sex- Specific Cases of the Hepatitis A *
5.5.5. Diagnosed Cases of the Hepatitis A
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Hepatitis A
5.6.3. Sub-Type Specific cases of the Hepatitis A *
5.6.4. Sex- Specific Cases of the Hepatitis A *
5.6.5. Diagnosed Cases of the Hepatitis A
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Hepatitis A
5.7.3. Sub-Type Specific cases of the Hepatitis A *
5.7.4. Sex- Specific Cases of the Hepatitis A *
5.7.5. Diagnosed Cases of the Hepatitis A
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Hepatitis A
5.8.3. Sub-Type Specific cases of the Hepatitis A *
5.8.4. Sex- Specific Cases of the Hepatitis A *
5.8.5. Diagnosed Cases of the Hepatitis A
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Hepatitis A
5.9.3. Sub-Type Specific cases of the Hepatitis A *
5.9.4. Sex- Specific Cases of the Hepatitis A *
5.9.5. Diagnosed Cases of the Hepatitis A
6. Unmet Needs of the Hepatitis A
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

List of Tables :


Table 1: Total Prevalent/Incident Cases of the Hepatitis A in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis A in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis A in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Hepatitis A in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Hepatitis A in United States (2016-2028)*
Table 6: Diagnosed Cases of the Hepatitis A in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Hepatitis A in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Hepatitis A in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Hepatitis A in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Hepatitis A in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Hepatitis A in France (2016-2028)
Table 12: Sub-Type Specific cases of the Hepatitis A in France (2016-2028) *
Table 13: Sex- Specific Cases of the Hepatitis A in France (2016-2028) *
Table 14: Diagnosed Cases of the Hepatitis A in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Hepatitis A in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Hepatitis A in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Hepatitis A in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Hepatitis A in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Hepatitis A in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Hepatitis A in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Hepatitis A in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Hepatitis A in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Hepatitis A in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Hepatitis A in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Hepatitis A in UK (2016-2028) *
Table 26: Diagnosed Cases of the Hepatitis A in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Hepatitis A in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Hepatitis A in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Hepatitis A in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Hepatitis A in Japan (2016-2028)

List of Figures :

Figure 1: Total Prevalent/Incident Cases of the Hepatitis A in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis A in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis A in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Hepatitis A in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Hepatitis A in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Hepatitis A in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Hepatitis A in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Hepatitis A in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Hepatitis A in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Hepatitis A in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Hepatitis A in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Hepatitis A in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Hepatitis A in France (2016-2028) *
Figure 14: Diagnosed Cases of the Hepatitis A in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Hepatitis A in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Hepatitis A in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Hepatitis A in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Hepatitis A in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Hepatitis A in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Hepatitis A in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Hepatitis A in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Hepatitis A in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Hepatitis A in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Hepatitis A in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Hepatitis A in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Hepatitis A in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Hepatitis A in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Hepatitis A in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Hepatitis A in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Hepatitis A in Japan (2016-2028)

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3250
This license allows only one user to access the PDF.

Electronic (PDF)
$6500
This license allows all the users of an enterprise residing in one location to access the PDF

Electronic (PDF)
$9750
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Bioinformatics Barcelona

RELATED REPORTS

Global Flu Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Flu Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

In 2020 the global Flu Vaccine market size was US 5154 million and it is expected to reach US 7293.3 million by the end of 2027 with a CAGR of 4.8 during 20212027.Global Flu Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 20212027.

120 Pages
Type: Report
Code: QYRE-Auto-11H675
Mon Sep 27 00:00:00 UTC 2021

Add to Cart

Global Rabies Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Rabies Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

And in terms of application the largest application is Postexposure Prophylaxis followed by Preexposure Prophylaxis.Market Analysis and Insights Global Rabies Vaccine MarketIn 2020 the global Rabies Vaccine market size was US 877 million and it is expected to reach US 1178 million by the end of 2027 with a CAGR of 4.0 during 20212027.Global Rabies Vaccin.

120 Pages
Type: Report
Code: QYRE-Auto-34M23
Mon Sep 27 00:00:00 UTC 2021

Add to Cart

Global and United States Sulfachloropyridazine Sodium Market Insights Forecast to 2027
Global and United States Sulfachloropyridazine Sodium Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-28M6619
Tue Sep 21 00:00:00 UTC 2021

Add to Cart

Global and United States Tick borne Encephalitis Inactivated Vaccine Market Insights Forecast to 2027
Global and United States Tick-borne Encephalitis Inactivated Vaccine Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-34O6484
Sun Sep 05 00:00:00 UTC 2021

Add to Cart